<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="the Global Burden of Disease (GBD) study, promoted by the" exact="World Health Organization," post="reported migraine as the most disabling neurological disorder, and"/>
 <result pre="an agonist or antagonist would show efficacy for migraine. Nonetheless," exact="Amgen" post="recently published preclinical pharmacology and human safety data on"/>
 <result pre="modulation of these channels. Funding GD receives support from the" exact="National Institutes of Health" post="(NS104200, NS104990, NS107058,NS098826) and grant support from Alder Biopharmaceuticals"/>
 <result pre="Miljkovic J. Cordasic N. Will C. Kichko T.I. de la" exact="Roche" post="J. Fischer M. Suarez S.A. et al. H2S and"/>
</results>
